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Fibroblast growth factor (FGF) signaling is required prior to gastrulation in the mouse embryo. To test for the spatial and
temporal requirements of FGF signaling, a dominant negative FGF receptor (dnFGFR) was used to make transgenic mouse
embryos. In mosaic embryos, cell division ceased at the ®fth cell division in all cells that expressed the mutant receptor,
but cell death did not increase. After the ®fth cell division, the progeny of unaltered cells and cells expressing lacZ continued
to accumulate at the same rate, suggesting that the FGF requirement is cell autonomous. In mosaic embryos, lacZ,
but not dnFGFR expression was detected in mitotic trophoblasts adjacent to the ICM. Conversely, dnFGFR-expressing
extraembryonic ectoderm cells were detected at the abembryonic pole in postmitotic cells. In blastocysts expressing the
dnFGFR in all cells, the morphology appeared normal and inner cell masses (ICMs) formed, but resultant embryos had
only one-third the number of cells as control embryos. In these blastocysts, cell division had also ceased at the ®fth cell
division, but cavitation, a concurrent morphogenetic event, initiated and progressed normally. To test for the continuing
requirement of FGF, FGFR-3 was overexpressed in all cells and resulted in an increase in cell numbers after the ®fth cell
cycle. In a model for postimplantation development, addition of FGF-4 to blastocyst outgrowths increased the number of
extraembryonic ectoderm cells, suggesting a continuing role for FGF. Thus, FGF signaling induces the cell division of
embryonic and extraembryonic cells in the preimplantation mouse embryo starting at the ®fth cell division. The signal
requirement for FGF is cell autonomous, but is not required to prevent cell death. This provides the ®rst evidence for the
necessity of a growth factor before implantation. q 1998 Academic Press
INTRODUCTION Fibroblast growth factor (FGF) signaling is essential for
embryonic development in mice. Loss of a single FGF ligand
family member (FGF-4) in the mouse is lethal soon afterIn mammals, the peri-implantation period is the time of
implantation (Feldman et al., 1995). In the fgf4 null mutant,greatest embryonic failure and loss (Cross et al., 1994). Em-
the embryo implants into the uterus at 4.5 days after fertil-bryonic growth before implantation is density-dependent in
ization (E4.5), but degenerates within 1±2 days. In an invitro, suggesting that cell division is regulated by diffusible
vitro model for early postimplantation events, the fgf4 nullfactors. Growth factors including members of the insulin
blastocyst grows out extraembryonic ectoderm cells, butfamily and CSF-1 are suf®cient to regulate cell division be-
the ICM dies within 2 days. Overexpression of FGF-4 in afore implantation (Rappolee and Werb, 1994; Rappolee,
culture of isolated ICM cells leads to increased production1998). However, no growth factor has been shown to be
of yolk sac endoderm, suggesting an FGF in¯uence on ICMnecessary for cell division before implantation.
and/or early endoderm (Rappolee et al., 1994). Trophoblast
and ICM cells divide suf®ciently to produce a morphogenet-
ically normal fgf4 null blastocyst (Feldman et al., 1995).1 Current address: Vysis Inc., 3100 Woodcreek Dr., Downer's
Grove, IL 60515. However, since there is maternal FGF-4 mRNA in the oo-
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Cross et al., 1995). The PGK promoter was based upon a sequencecyte (Rappolee et al., 1994), suf®cient signal input in fgf4
described previously (McBurney et al., 1991). To synthesize thenull mutant may continue for a number of zygotic cell divi-
dnFGFR, a BamHI±XbaI cDNA fragment containing the ®rst 9sions. Other FGF ligands may also provide suf®cient FGF
exons of FGFR-4 was excised from pKSFGFR-4 (Stark et al., 1991),to sustain the embryo in early cell divisions.
resulting in a complete truncation of the tyrosine kinase domain.The FGF family consists of 15 FGF ligand (FGF-1 through
This was ligated downstream of the myogenin promoter in a pSP72
FGF-15) genes of related sequence (Basilico and Moscatelli, vector (Yee and Rigby, 1993) to produce the pSP72MyodnFGFR
1992; Smallwood et al., 1996; Rappolee, 1997). The ®rst 9 vector. A KpnI±XbaI genomic DNA fragment of FGFR-4 was used
ligands are the best characterized. These heparin-binding to replace exons 5±9 of the FGFR-4 cDNA genes. The pSP72 vector
factors are between 14 and 28 kDa. Some are secreted (FGF- contained a XbaI±HindIII fragment of bPA (Stewart et al., 1992). An
4 through FGF-9), while some lack the signal sequences oligonucleotide encoding a human myc epitope tag (EQKLISEEDL)
recognized by the 9E10 hybridoma (Evan et al., 1985) was clonedrequired for secretion (FGF-1 through FGF-3). FGF-4 is ex-
into the XbaI site between the 3* terminus of the truncated mutantpressed in the ICM, but FGF-2 and FGF-3 have not been
of pSP72Myo-dnFGFR and the bPA site. This vector was nameddetected in the blastocyst (Rappolee et al., 1988, 1994).
pSP72Myo-dnFGFRmycbPA and was used for another line of exper-There are four high-af®nity FGF receptors (FGFR-1
iments. For synthesis of pPGKdnFGFRmycbPA, the myogenin pro-through FGFR-4; Kd 20±480 pM). FGFR-1 through FGFR-
moter was digested with BamHI, blunted, and then excised with4 are related transmembrane receptors with split-tyrosine
ClaI. The PGK promoter was digested in the PGKneo vector (Stew-
kinase domains which require FGF ligand-dependent dimer- art et al., 1992) with PstI and then blunted and excised with ClaI
ization for activation. Both tyrosine kinase activity and the and directionally cloned into the ClaI site in the pSP72 vector to
split domain are required for mitogenic activity (Partanen create pSP72PGKdnFGFRmycbPA. The entire PGKdnFGFRmyc-
et al., 1992; Johnson and Williams, 1993). An obligate low- bPA transgene was removed as a HindIII fragment and cloned into
af®nity FGF receptor (Kd  10 nM), such as syndecan (a the HindIII site in the PGKneobPA vector to create a vector with
independent PGKneobPA and PGKdnFGFRmycbPA transgenes.sulfated heparin), is believed to alter the FGF ligand and
This construct is referred to as pPGKdnFGFRmyc. All referencesallow it to bind high-af®nity receptors. There is cross-reac-
in the text to expression of dnFGFR refer to this construct.tivity between the four receptors and FGF-1 through FGF-
A full-length FGF-4 was a gift of Dr. Martin (Hebert et al., 1990).9 (Ornitz et al., 1996), although some alternately spliced
For pPGK-FGF-4, the neo gene was removed from the pPGK-neo-forms of FGFR-1 through FGFR-3 have ligand speci®city.
bPA vector (Stewart et al., 1992; McBurney, 1991) and replacedIsoforms of all four FGF receptors bind FGF-4. FGFR-1, -3,
with the XbaI±PstI fragment of the full-length coding sequence ofand -4 mRNA have been detected in the blastocyst (Rap-
mouse FGF-4 from FGF-K clone-12 (Hebert et al., 1990) by blunt-
polee et al., 1994; Rappolee, 1998). FGFR-2 mRNA is de- end cloning. For the pPGKFGFR-4, a SalI±NotI fragment of the
tected in the early postimplantation embryo (Orr-Urtreger full-length FGFR-4 gene was excised from pKSFGFR-4-Comp (Stark
et al., 1991). et al., 1991) and replaced the excised neo gene by blunt-end cloning
In this report, we have used a dnFGFR to test preimplan- (Stewart et al., 1992). For pPGKFGFR-3, a HindIII±XbaI fragment
tation embryos for the time and location of their require- of the full-length wild-type gene was removed from MomFR3SV
(Ornitz et al., 1992) and directionally cloned into the pPGKneobPAment for FGF signal input. Surprisingly, ICM and adjacent
after the neo gene was excised.trophoblast cells require FGF receptor signaling to divide
All the techniques used in transgene construction were standardbeginning at the ®fth cell division, which occurs before
techniques (Ausubel, 1993). All transgenes were transiently trans-implantation.
fected into NIH3T3 ®broblasts or F9 teratocarcinoma stem cells or
microinjected into one blastomere at the two-cell stage to produce
mosaic embryos. The cells or mosaic embryos were then assayed for
MATERIALS AND METHODS protein production by indirect immunocytochemistry (Rappolee et
al., 1994). This test of expression for transgenesis was done for
pPGKdnFGFRmyc, pPGKFGFR-4, pPGKFGF-4, and pPGKFGFR-3.Materials. AmpliTaq DNA polymerase was purchased from
Mouse eggs and embryos. Standard techniques were used forPerkin±Elmer Cetus (Norwalk, CT). Restriction enzymes and T4
obtaining eggs and zygotes. Female CD-1 (6±10 weeks old, Charlespolynucleotide kinase were purchased from New England BioLabs
River, Wilmington, MA) or MF-1 (Harlan Sprague±Dawley, India-(Beverly, MA) and Gibco/BRL (Gaithersburg, MD). X-Phosphate (5-
napolis, IN) were mated with C57BL/6J X SJL/J F1 hybrid malesbromo-4-chloro-3-indolyl phosphate) was purchased from Boeh-
(Jackson Laboratories, Bar Harbor, ME). Noon of the day followingringer-Mannheim Biochemicals (Indianapolis, IN). Hoechst 33258
coitus was considered day E0.5. Embryos were obtained at the fol-was purchased from Eastman Kodak Co. (Rochester, NY). All other
lowing stages: E0.5 (fertilized zygote), E1.5 (two-cell stage), and E4.5chemicals were from Sigma Chemical (St. Louis, MO) or VWR
(late cavitation blastocyst).(Chicago, IL). Agarose was from FMC (Rockland, ME). Laminin
Embryo culture and microinjection. Preimplantation embryosantibody was purchased from ICN (Costa Mesa, CA), 9E10 hybrid-
were cultured in serum-free microdrop culture under oil in CZBoma was obtained from Dr. Bishop (Evan et al., 1985), and recombi-
or KSOM media (Specialty Media, Lavallette, NJ). Postimplantationnant FGF-4 and anti-FGF-4 were gifts of Dr. Basilico (Rappolee et
embryos were cultured in Ham's F-12 with 4% FCS (Invitrogenal., 1994). Polyclonal antisera to FGFR-3 and FGF-4 were purchased
low retinoic acid test) with or without 10 ng/ml recombinant FGF-from Santa Cruz Biotechnology (Santa Cruz, CA).
4. Approximately 0.5±1 pl of circularized DNA plasmids was mi-DNA. pPGKneobPA (PGK, phosphoglycerate kinase; bPA, bo-
croinjected into the male pronucleus of single-cell zygotes or 0.5vine growth hormone polyadenylation site) was a gift from C. Stew-
art and b-actin lacZ was a gift from J. Cross (Stewart et al., 1992; pl into a nucleus of one blastomere in the two-cell zygotes by
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standard techniques (Hogan et al., 1994). In the circular form, ex- segments. Since the ICM is nearly always positive and we wanted
to score only trophectoderm cells, we scored segments one andpression is favored over integration (Brinster et al., 1985). The con-
eight as positive only if expression was detected in the outer extra-centration of plasmid microinjected was 10 ng/ml of PGKdnFGFRmyc;
embryonic ectoderm cells.20 ng/ml of b-actinlacZ; 10 ng/ml of PGKFGFR-4, PGKFGFR-3, and
Analysis of blastocyst outgrowths. To test the ability of em-pPGKFGF-4; or a combination of 10 ng/ml PGKdnFGFRmyc and 20
bryos to form outgrowths, E3.5 embryos were cultured in Ham'sng/ml b-actin lacZ. Embryos were cultured as described above and
F-12 with 10% FCS with or without 10 ng/ml FGF-4 for 3 days.morphology was recorded daily at ®xed times. Dead embryos were
Outgrowths were stained with Hoechst as above and photographed,removed from the media and not included in the analysis. Approxi-
and negatives were scanned using the Photoshop CD 3.0 program.mately 65% of all injected embryos progressed past microinjection
Some outgrowths were also analyzed for the number of laminin-through to compaction. During culture, some embryos microin-
positive cells. Sizes of outgrowths were measured with NIH Imagejected with lacZ or dnFGFR did not progress beyond the two-cell
1.57. All statistics were done with the Biostatistics 3.0 programstage. The transgenic embryos that did not progress beyond the
(Glantz, 1992) run on a Mac IIsi.two-cell stage were not analyzed. After 1 day, embryos were exam-
ined under the microscope to detect the number of cells and then
reincubated. After 2, 3, 4, 5. or 6 days in culture, embryos were
processed for nuclear counts by ®xation and Hoechst staining, as RESULTS
well as for expression of lacZ, dnFGFR, FGFR-4, and FGFR-3 trans-
genes. Uninjected or lacZ same-stage embryos were used as nega- Effects of expression of the dnFGFR begin at the ®fth
tive controls. Hoechst-stained embryos were counted in serial Z-
cell division and are cell autonomous. To assay for effectsaxis focal planes at the microscope in blinded experiments. All
of loss of FGF signal input in Xenopus, a dnFGFR has beenexperiments were done at least twice.
used previously (Amaya et al., 1991, 1993). This mutantImmunocytochemistry. To develop ®xed pPGKdnFGFR-myc,
receptor speci®cally blocks all input of FGF signal whenpPGKFGFR-4, pPGKFGF-4, and pPGKFGFR-3-injected embryos,
expressed to a greater degree than the endogenous receptorswe used the 9E10 clone of mouse anti-human myc hybridoma (Evan
et al., 1985) and anti-FGF-4, anti-FGFR-3 (Santa Cruz), and rabbit (Amaya et al., 1991). Due to the dimerization requirement
polyclonal anti-C* terminus FGFR-4 antibody as primary antibody, and the ability of all FGF receptors to heterodimerize (John-
respectively. Rabbits were immunized with the 14 amino acids at son and Williams, 1993), the function of all endogenous
the C-terminus of the FGFR-4 and antibodies were puri®ed using FGF receptors is blocked by this dnFGFR. We constructed
the oligopeptide as previously described (Partanen et al. 1992). Im- a dnFGFR by completely removing the tyrosine kinase do-
munocytochemistry was performed as described (Rappolee et al., main. The dnFGFR, FGFR-4, FGFR-3, and FGF-4 were ex-
1994), except that embryos were ®xed for 30 min in fresh 4 %
pressed using a strong constitutive promoter (PGK). Weparaformaldehyde and permeabilized for 5 min with 0.25% Triton
added a human myc epitope tag to analyze the expressionX-100. The anti-human myc supernatant was used neat and anti-
of the dnFGFR transgene.FGFR-4, anti-FGF-4, and anti-FGFR-3 were used at 1/400. Hoechst
Circularized plasmids injected at 1000±5000 copies per(10 mg/ml) was used as a counterstain. LacZ-expressing embryos
embryo achieved transgenesis throughout the period of pre-were developed in a microdrop assay under oil as previously de-
scribed (Behringer et al., 1993). For standard diascopic and epi¯uo- implantation development (Fig. 1). Mosaic embryos pro-
rescence micrography, a Nikon Microphot FXA microscope with a duced by this procedure are good tools for analyzing the
420-nm barrier ®lter and Walgreen's 100 ISO print ®lm were used. timing and location of FGF activity, since possible lethal
Objectives were chosen to cover the ®eld for pertinent detail at 4± events in the injected cells are not lethal to the embryo
201. Negatives were scanned into a Power PC computer using (Slack, 1991; Hogan et al., 1994). This approach has been
Adobe Photoshop 3.0. used previously to show that the basic helix-loop-helix
Assaying cell death in preimplantation embryos. For testing gene, Hxt, transdifferentiates cells into the extraembryonic
cell death, pyknotic nuclei were counted after Hoechst staining as
ectodermal cell lineage (Cross et al., 1995).previously described (Hogan et al., 1994). For the trypan blue test,
We expressed control lacZ and dnFGFR genes in mosaicembryos at each stage were shifted directly from medium to 0.4%
embryos. Expression was detected within hours of micro-trypan blue solution for 10 min and blue cells counted under the
injection at the two-cell stage and continued throughoutZeiss (West Germany) inverted microscope. Same-stage embryos
the culture of preimplantation embryos (Fig. 1). Duringwere ®xed and used as positive controls.
Analysis of mosaic embryos for position of dnFGFR and lacZ- culture of the mosaic embryo, the total number of cells in
expressing cells. Mosaic embryos were made for lacZ or dnFGFR the embryo was not affected during the ®rst 2 days or the
as described above. To lower the immunocytochemistry back- ®rst four cell divisions (Table 1). However, during the third
ground, lacZ was coinjected with dnFGFR and used to detect the day of embryo culture, or the ®fth cell division, a signi®-
position of these cells. Five days later embryos were processed for cantly lower cell number was detected in embryos express-
lacZ expression, stained with Hoechst, and micrographed. The ing the dnFGFR. We tested whether the effects of the
ICMs of the embryos were positioned at 12 o'clock by rotating
dnFGFR continued more than 3 days after microinjection.micrographs of Hoechst-stained embryos in the Adobe Photoshop
There was a continuing signi®cant de®cit in cell number3 application. To quantify the expression patterns of the transgenes
in dnFGFR-expressing embryos cultured for an additionalin the extraembryonic ectoderm, each blastocyst was overlaid with
2 days (Table 1).a circle divided into eight 457 segments so that the top of the blasto-
We used a full-length FGFR-4 gene to test two parame-cysts bisected the line between segments one and eight. We scored
segments two to seven as positive if any cell was stained in those ters: whether the effects of overexpression of a nonmito-
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dogenous FGFR-4 and patches of FGFR-4 overexpressing
cells could be detected by immunocytochemical means
(data not shown). Overexpression of FGFR-4 had no effect
on the number of cells in mosaic blastocysts at the third
day of culture (Table 1). When FGFR-4 was coinjected with
the dnFGFR transgene at equimolar concentrations of plas-
mid, it rescued the mosaic embryo to produce the same
number of cells as control embryos. These data suggest
that the effects of the dnFGFR are reversible and speci®c
to its activity in blocking endogenous FGF receptors. These
data agree with previous mouse data (Wang et al., 1994),
but contrast with the mitogenic effects of human FGFR-4
(Vainikka et al., 1994).
To assay for the cell autonomous nature of the defect in
cell division, embryos were analyzed for the number of cells
expressing the lacZ or dnFGFR transgene. The embryos
used for assaying total cell number (Table 1) were developed
to detect activity of the lacZ transgene and expression of
the myc-tagged dnFGFR. We assayed mosaic embryos at 2
and 3 days after microinjection, when the effect on cell
division was ®rst seen. During the second day of culture, the
lacZ- and dnFGFR-expressing embryos were evenly divided
into transgene-expressing cells and the progeny of unin-
jected cells (Table 2). By the third day, the cells expressing
the dnFGFR were about half the number of the progeny of
uninjected cells, but statistically not different in number
than the previous day. Also, the number of cells in the
progeny of uninjected cell was the same in the lacZ- and
dnFGFR-expressing embryos on the third day. To assay for
the accumulating effects of expression of dnFGFR, we ana-
lyzed the number of cells derived from the dnFGFR-injected
cell for an additional 2 days. There continued to be no differ-
ence in the number of progeny of the uninjected cell in the
dnFGFR- and lacZ-injected embryos. This suggests that the
effects of inhibition of FGF input are cell autonomous.FIG. 1. Cells expressing dnFGFR and lacZ are detected through-
Endogenous FGF does not prevent cell death. To deter-out the period of culture. The expression of lacZ (A, C, E, G) and
dnFGFR (B, D, F, H) transgenes starts at the two-cell stage, soon mine if FGF acts to induce cell division, two parameters
after microinjection (in one of the two cells) and continues for the were tested. First, it was determined that the number of
®rst 3 days of culture. LacZ was detected by its enzymatic activity cells expressing the dominant negative in mosaic embryos
and dnFGFR was using antibody to the myc epitope tag. Embryos did not change signi®cantly after day 2 (Table 2). Second, we
are not all to the same scale. I and J are uninjected embryos devel- assayed for cell death in the lacZ- and dnFGFR-expressing
oped to detect the expression of lacZ or dnFGFR, respectively. Ar-
mosaic embryos. Normalized to the total number of cells,rowheads show expressing patches and arrows show nonexpressing
there was no signi®cant difference in the fraction of pyk-cells. C, days in culture.
notic cells in the ICM after 5 days of culture of lacZ or
dnFGFR transgenic embryos (lacZ: 3.7 { 0.5%, n  19;
dnFGFR: 3.9 { 0.5%, n  20; P  0.8). Trypan blue was
used to detect dead cells on the outside epithelium, thegenic FGFR could inhibit cell division and whether the
effects of the dnFGFR were reversible. The murine FGFR- extraembryonic ectoderm. At days 2±5 of culture, there
were no dead cells in embryos transgenic for dnFGFR (04 is weakly enzymatic, with little or no mitogenic or enzy-
matic function in cell lines (Wang et al., 1994; Ornitz et dead cells in 67 embryos) or lacZ (0 dead cells in 71 em-
bryos). These data suggest that FGF is not required for theal., 1992). FGFR-4 can phosphorylate itself and some sub-
strates such as phospholipase C-g, but not as strongly as prevention of cell death in the preimplantation embryo.
Division of trophoblast cells requires FGF. PreviousFGFR-1 (Wang et al., 1994). FGFR-4 mRNA and protein
are detected throughout the embryo at E3.5 (Rappolee et reports suggested that FGF-4 regulated survival of the ICM
and the growth of endoderm that arises from it (Feldman etal., 1994; Jacobson and Rappolee, unpublished data). Using
pPGKFGFR-4, we expressed levels of FGFR-4 protein in al., 1995; Rappolee et al., 1994). Our results suggest that
FGF signaling controls cell division in the ICM and surpris-mosaic embryos that were greater than the amount of en-
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TABLE 1
Effects of the Expression of a Mutant and Wild-Type FGF Receptors in the Preimplantation Mouse Embryo
Total cell number/mosaic embryo
Days after microinjection
Transgene 0 1 2 3 4 5
LacZ, total cellsa 2 { 0 6.8 { 0.1 19.4 { 0.5 36.1 { 0.9 57.9 { 3.0 78.9 { 4.3
No. embryos 156 135 37 68 26 25
dnFGFR total cells 2 { 0 6.9 { 0.1 18.8 { 0.5 26.9 { 0.9 42.6 { 3.6 58.4 { 4.9
No. embryos 169 129 (P  0.7b) 41 (P  0.4b) 79 (P  0.001c) 25 (P  0.002c) 24 (P  0.003c)
dnFGFR / FGFR-4 Ð Ð Ð 38.9 { 3.3 Ð Ð
No. embryos 40 (P  0.8d)
FGFR-4 alone Ð Ð Ð 34.1 { 2.0 Ð Ð
No. embryos 23 (P  0.9e)
a These data were derived from seven sets of microinjections. Total counts are recorded as means { SEM.
b At days 1 and 2, the total cell number in lacZ and dnFGFR mosaic embryos was not signi®cantly different.
c At days 3, 4, and 5, the total cell number in lacZ and dnFGFR mosaic embryos was signi®cantly different.
d,e At day 3, the total cell number in mosaic embryos expressing lacZ, dnFGFR / FGFR-4, and FGFR-4 alone was not signi®cantly
different.
ingly in extraembryonic ectoderm. If FGF is required for We made mosaic embryos as described above, oriented
the ICM at the top of the micrographs (Fig. 2), and thencell division in the extraembryonic ectoderm, other effects
are predicted. Mitotic trophoblasts that produce the extra- scored for the presence of transgenic cells in eight 457 seg-
ments of the embryo. Segments one and eight included theembryonic ectoderm are in contact with and adjacent to
the ICM (Gardner et al., 1973; Cruz and Pedersen, 1985; ICM and segments four and ®ve were at the opposite abem-
bryonic pole. The tabulated data (Table 3) show that onlyreviewed in Pedersen, 1987). Postmitotic progeny of tropho-
blasts are pushed away from a position near the ICM by 1/54 of the dnFGFR-expressing mosaic embryos were posi-
tive in segments one or eight, whereas 46/50 of the lacZ-population pressure. If expression of the dnFGFR transgene
prevents cell division in these trophoblasts, then dnFGFR expressing embryos were positive in these segments. Extra-
embryonic ectoderm cells in segments two to seven containexpression cannot endure in trophectoderm cells near the
ICM in mosaic embryos. almost all dnFGFR-expressing cells, whereas segments ex-
TABLE 2
The Cell Autonomous Nature of FGF Signal Input in the Regulation of Cell Division
Cell number/patch in mosaic embryos
Days after microinjection
Transgene 2 3 4 5
LacZ, staineda 9.0 { 0.7 18.3 { 1.1 27.4 { 1.5 36.3 { 1.5
No. embryos 18 27 20 20
LacZ, unstained 8.3 { 0.7 (P  0.5b) 17.7 { 1.3 (P  0.5b) 29.9 { 1.6 (P  0.2b) 41.7 { 2.9 (P  0.3b)
No. embryos 18 27 20 20
dnFGFR, stained 7.5 { 0.7 8.5 { 0.6 (P  0.6c) 9.5 { 0.6 (P  0.6c) 9.5 { 0.6 (P  0.6c)
No. embryos 21 52 23 21
dnFGFR, unstained 9.0 { 0.8 (P  0.5d) 16.3 { 1.2 (P  0.001d) 33.2 { 1.5 (P  0.001d) 45.9 { 2.7 (P  0.001d)
No. embryos 21 52 23 21
a These data were derived from experiments described in Table 1. After the total cell counts were done, embryos were stained for lacZ
gene activity or for the presence of the myc tag on the dnFGFR. The number of cells are recorded as means { SEM.
b At days 2, 3, 4, and 5, the number of unstained cells in lacZ and dnFGFR mosaic embryos was not signi®cantly different.
c At day 3, 4, and 5, the number of stained cells in dnFGFR mosaic embryos was not signi®cantly different from day 2.
d At days 3, 4, and 5, the number of stained cells in dnFGFR or lacZ mosaic embryos was signi®cantly different. At day 2, the number
of stained cells in dnFGFR or lacZ mosaic embryos was not signi®cantly different.
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FIG. 2. The location of the dnFGFR transgene can be detected in ICM cells and trophectoderm cells, but not in immediate progeny of
mitotic trophoblast cells. LacZ (A, B) tends to be expressed (arrowhead) in the ectoderm near the ICM (arrow). dnFGFR (C, D) is expressed
in the ectoderm away from the ICM (arrowhead) in mosaic embryos 5 days after microinjection. The dnFGFR is detected in the ICM
(arrow). The location of transgene expression was detected by lacZ enzymatic activity.
pressing lacZ are equally distributed with a tendency to entiate. To test whether expression of dnFGFR affects differ-
entiation, we microinjected transgenes for dnFGFR, or con-segments one, two, seven, and eight. These results suggest
that dnFGFR-expressing extraembryonic ectodermal cells trol neo or lacZ, into the pronuclei of fertilized one-cell
zygotes to produce expression in every cell in the blastocystbecome postmitotic and do not remain near the ICM.
Expression of a dnFGFR does not affect early embryonic (Fig. 3, upper panel). Typically, 90±95% of the microin-
jected embryos expressed transgene in every cell (data notdifferentiation events. The expression of the dnFGFR
might cause cells to cease division by causing them to differ- shown). We detected no difference between dnFGFR- or
TABLE 3
The Location of Cells Expressing the dnFGFR in Mosaic Embryos
Number of embryos having at least one cell in a given segment
Segment
1 8
Transgene (near ICM) 2 3 4 5 6 7 (near ICM) Sample size
LacZ 45 40 28 29 28 37 43 42 50
dnFGFR 1 22 31 37 35 30 21 1 54
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Hogan et al., 1994). Cavitation occurs at the time that the
expression of the dnFGFR results in cessation of cell divi-
sion. As in the mosaic embryos, no difference in total cell
number between lacZ- and dnFGFR-expressing cells was
seen 2 days after microinjection (data not shown). However,
by the sixth day of this culture period, the embryos
transgenic for dnFGFR had about one-third of the number
of cells as embryos transgenic for lacZ (Table 4). As in the
mosaic embryos, the cessation of cell growth occurred after
the fourth cell division. However, the morphology and vol-
ume (Fig. 3, lower panel; lacZ: 74.7 { 6.3 arbitrary units3
vs dnFGFR: 70.8 { 5.0 arbitrary units3; P  0.6, two experi-
ments, n  63) of the embryo at the end of cavitation were
the same in dnFGFR- and lacZ-expressing embryos. Em-
bryos expressing the dnFGFR in all cells developed ICMs
at high frequency (Fig. 3, lower panel), suggesting there was
no qualitative requirement of endogenous FGF signaling on
allocation to the ICM.
These data suggest that early differentiation events oc-
curring at the time of the ®rst FGF-mediated cell growth
are not affected by the loss of FGF signal input. We also
tested for effects of dnFGFR on later differentiation events.
The dnFGFR-expressing embryos had reduced hatching
from the zona pellucida, did not attach to ®bronectin-coated
substrates, and had no outgrowth of extraembryonic ecto-
derm cells (Table 4, day 7). In similar experiments using
different media conditions (CZB cf KSOM) and a different
strain of mice (CD-1 cf MF-1), no dnFGFR-expressing em-
bryos attached and grew out (0/58), but 35% (22/63) of con-
trol embryos transgenic for neo attached and grew out.
These data suggest that cavitation is not affected by the
expression of the dnFGF receptor. Although cells expressing
the dnFGFR stopped dividing in the ®fth cell division, mor-
phogenetic events proceeded at a rate that was the same as
control embryos that expressed lacZ. Later differentiation
events, attachment and outgrowth, were affected by expres-
sion of the dnFGFR transgene.
FGFR-3 overexpression increases the number of cells in
FIG. 3. Preimplantation embryos expressing the dnFGFR in all the blastocyst. FGF-4 protein added outside cultured pre-
cells differentiate normally, but produce fewer cells than embryos implantation embryos had no effect on cell number (Rap-
expressing lacZ. In the upper panel, a characteristic blastocyst ex-
polee et al., 1994), but expression of the dnFGFR suggestspresses lacZ (A) in every cell as detected by the enzymatic activity
that endogenous FGF signaling is required for cell divisionof lacZ. Phase contrast of the same blastocyst (B). In the lower
at the ®fth cell division. To reconcile these ®nding and topanel, Hoechst-stained dnFGFR-expressing blastocysts (C) have
test for the continuing in¯uence of FGF after the ®fth cellfewer cells than lac Z-expressing embryos (A) (see cell counts in
division, embryos were tested for cell number after FGFR-Table 4), but the morphology of dnFGFR-expressing embryos (D)
and lacZ-expressing embryos (B) appears the same. Embryos were 3 or FGF-4 transgenes were overexpressed alone or together
injected at 0.5 days after fertilization (E0.5). All embryos were ob- in every cell in the preimplantation mouse embryo.
served at 6C. C, days in culture. Note that nuclei in the embryos FGFR-3 mRNA and protein are detected in all cells of the
with low cell number (dnFGFR-expressing embryos) appear less E3.5 blastocyst at high levels (Rappolee et al., 1994; Jacob-
bright due to spreading of fewer nuclei over a similar volume. In son and Rappolee, unpublished data). It is enzymatically
A and C, arrows show ICMs.
active and weakly mitogenic and is activated by FGF-4 (Or-
nitz et al., 1992, 1996). The overexpression of FGFR-3 in
all cells of the early embryo increases the number of cells
signi®cantly 6 days after microinjection (Table 5), sug-lacZ-injected transgenic embryos in the initiation, timing,
or progression of embryo development of compaction or gesting that enzymatically active FGF receptors can have
signi®cant effects on cell number in the preimplantationcavitation (Table 4, days 3±6), two early differentiation
events in mouse development (Rappolee and Werb, 1994; mouse embryo. However, overexpression of FGF-4 had no
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TABLE 4
Timing and Number of dnFGFR-Expressing Embryos Undergoing Compaction, Cavitation, and Outgrowth
Cumulative number of embryos at given stages of differentiation
Days after microinjection
Transgene 3 4 5 6 7
LacZa
Compacted 7 38 0 0
Cavitated 0 9 47 47
Total cell number (No. embryos) 72.8 { 6.2 (28)
Outgrowing (total No. embryos) 13 (19)
dnFGFR
Compacted 9 33 0 0
Cavitated 0 10 43 43
Total cell number (No. embryos) 24.1 { 1.3 (29)
Outgrowing (total No. embryos) P  0.001b 0 (14)
a In two experiments, 94 embryos were microinjected at day 0 and cultured in KSOM for 4 days. The number of embryos that compacted
and cavitated was assayed at days 3±6. At day 4, 19 lacZ- and 14 dnFGFR-expressing embryos were removed and cultured in Ham's F-12
with 10% FCS to obtain outgrowths. At day 6, the embryos remaining in KSOM were ®xed and assayed for cell number. Four embryos
were lost during handling or degenerated between days 3 and 6 in culture.
b The differences in the mean number of cells in blastocysts microinjected with lacZ and dnFGFR were highly signi®cant as assayed
by Student's t test.
effect on cell number when injected alone. Also, FGF-4 did the same as FGFR-3. The coinjection of FGFR-3 and FGF-
4 resulted in signi®cant increases in cell numbers 5 and 6not increase the number of cells when coinjected with
FGFR-3 compared with embryos injected with FGFR-3 days after injection.
Taken together, these data suggest that the mouse em-alone. In a dose response, the concentration of FGFR-3 in-
jected was found to be maximal for stimulating cell number bryo continues to be sensitive to FGF after the ®fth cell
division. In mediating cell division, FGF ligands appear toincreases (data not shown). The concentration of FGF-4 was
TABLE 5
The Effects of FGFR-3 Alone and Together with FGF-4 in the Preimplantation Mouse Embryo
Days after microinjection
Transgenea 5 6
LacZ
Total cell number (No. embryos) Ð 71.4 { 2.2 (23)
FGF-4
Total cell number (No. embryos) Ð 74.6 { 2.2 (29) (P  0.306b)
LacZ
Total cell number (No. embryos) Ð 72.2 { 2.3 (23)
FGFR-3
Total cell number (No. embryos) Ð 82.4 { 2.7 (26) (P  0.007b)
LacZ
Total cell number (No. embryos) 46.5 { 2.0 (23) 68.0 { 1.7 (26)
FGFR-3 / FGF-4
Total cell number (No. embryos) 54.3 { 2.6 (21) (P  0.006b) 79.8 { 2.3 (25) (P  0.001b) (P  0.469c)
a All experiments were done twice and the results shown are cumulative.
b The differences in the mean number of cells in blastocysts microinjected with lacZ and FGFR-3 or lacZ and FGFR-3 / FGF-4 were
signi®cant as assayed by Student's t test, but the difference between lacZ- and FGF-4-expressing embryos was not signi®cant.
c The difference in the mean number of cells in blastocysts microinjected with FGFR-3 and FGFR / FGF-4 was not signi®cant.
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In this report, we used a dnFGFR to show that endogenous
FGF signaling is required for the cell division of extraembry-
onic and embryonic cells at the ®fth cell division of the
mouse embryo. The effect was cell autonomous since the
cell division of progeny of uninjected cells in mosaic em-
bryos was unaffected. At the ®fth cell division, the two
affected mitotic cell populations were responsible for for-
mation of all embryonic and extraembryonic cell lineages.
FGF was not required for prevention of cell death in the
embryos, but cells expressing dnFGFR went into cell divi-
sion stasis. The static position in the cell cycle of the
dnFGFR-expressing cells is being studied.
FGF is not required for essential early differentiation
events. FGF was not required for compaction, the ®rst
essential differentiation event in the mouse. Growth factors
have not been implicated in the mechanism of compaction
(Rappolee, 1997). FGF was also not required for initiation
or maintenance of cavitation, since cavitation initiates soon
after the cells expressing the dnFGFR stopped dividing. Cav-
itation can be regulated in vitro by addition of epidermal
growth factor (Dardik and Schultz, 1991), but not by addi-
tion of FGF-4 (Rappolee et al., 1994; unpublished data).
FGF was not required for the initial allocation of ICM
cells as embryos expressing dnFGFR in all cells developedFIG. 4. Normal blastocysts grow out more extraembryonic ecto-
ICMs. These data suggest that the cessation of cell cyclederm when recombinant FGF-4 is present. (A) In culture with media
does not immediately lead to differentiation of ICM intoalone (37.7 { 3.7 outgrowing cells) and with FGF-4 (48.7 { 4.9
cells; P  0.01). (B) The outgrowths cover a surface area that is endoderm or trophectoderm cells. These studies require
proportional to the number of nuclei in the outgrowth. For media testing with markers for each cell lineage and differentia-
alone (909 { 37.7 arbitrary units of area) and for FGF-4 (1,604 { tion state to ®nd if FGF mediates quantitative effects.
53.5 arbitrary units of area, P  0.01). Other differentiation events that occurred after cavitation
appeared to be blocked by blocking FGF signal input. In
our studies, blocking FGF input resulted in prevention of
attachment and outgrowth of the blastocyst in vitro. How-be saturating and the concentration of endogenous FGF re-
ever, the dnFGFR-expressing embryos ceased cell divisionceptors is limiting.
earlier at the time of cavitation and the effects on laterFGF-4 increases outgrowth of extraembryonic ectoderm
differentiation events may be indirect.in blastocyst outgrowths. Results presented here suggest
The role of FGF in mediating division of extraembryonicthat FGF input is required for cell division in extraembry-
ectoderm cells. The ICM induces the cell division of adja-onic ectoderm in preimplantation embryos. Can FGF con-
cent trophoblasts (Gardner et al., 1973). Transplanted ICMstinue to in¯uence the growth of extraembryonic ectoderm
induce ectopic cell division in extraembryonic ectoderm inafter implantation? To test this, FGF-4 protein was added
recipient blastocysts. Extraembryonic cells next to the ICMto blastocyst outgrowth culture. FGF-4 increased the num-
are mitotic and cells injected with tracers produce postmi-ber of outgrowing cells determined to be trophectoderm
totic progeny that are displaced from the pole of the embryoby morphological (had large nuclei) and antigenic (lacked
containing the ICM (Copp et al., 1978, 1979; Cruz and Ped-expression of laminin) criteria. The increase in number of
ersen, 1985). Our results suggest that FGF is required for celltrophectoderm cells was proportional to the increase in the
division in the extraembryonic ectoderm and that increasedsize of the outgrowth (Fig. 4), suggesting that FGF-4 can act
FGF-4 can increase the number of trophectoderm cells.as a growth factor, but does not cause scattering of the
ICM-derived FGF-4 may be required for this cell division oftrophectoderm cells. These data indicate that FGF-4 contin-
polar trophoblast cells. If so, reexamination of the fgf4 nullues to regulate the division of extraembryonic ectoderm
mutants may detect a failure of cell division in these cells.cells in cultured embryos after the ®fth cell division and
Phenotypes of FGF mutants in early mouse development.after implantation.
The phenotype of embryos expressing the dnFGFR occurs
earlier than the fgf4 null mutant. In the fgf4 null mutant,
the blastocyst appeared normal but degenerated in uteroDISCUSSION
after implantation began. In vitro, the ICM degenerated ®rst
and the endoderm rising from the ICM apparently neverFGF mediates cell division by a positive, cell autono-
mous regulatory signal required at the ®fth cell division. formed. Conversely, in the dnFGFR-expressing embryo, the
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embryo stopped dividing before implantation, although the This implies a role for FGF in embryonic regulation of im-
plantation and the regulation of cell cycle.morphology of the embryo appeared normal. It is likely that
maternal FGF-4 mRNA transcripts (Rappolee et al., 1994)
and protein sustain the fgf4 null embryos and the lethal
phenotype occurs when these molecules are depleted. Other ACKNOWLEDGMENTS
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